LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Phase 2CompletedNCT00328588

Astellas Pharma Inc37 enrolled

Overview

A study for the treatment of Non-Small Cell Lung Cancer (NSCLC) in patients previously treated with chemotherapy.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Lung Cancer Cancer of Lung Cancer of the Lung Non-Small Cell Lung Carcinoma Carcinoma, Non-Small Cell Lung

Interventions

YM155DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histologically or cytologically confirmed non-small cell lung cancer. * Prior chemotherapy regimen(s) for lung cancer Exclusion Criteria: * History of other malignancy in the last 5 years * Major surgery within the past 21 days

Locations (8)

Unnamed facility

Chomutov, Czechia

Unnamed facility

Novi Jicin, Czechia

Unnamed facility

Ostrava, Czechia

Unnamed facility

Prague, Czechia

Outcomes

Primary Outcomes

Tumor response rate (CR+PR)

Time frame: In first 6 cycles

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.